Skip to Content

Hologic Inc HOLX

Morningstar Rating
$73.48 −0.05 (0.07%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

HOLX is trading at a 224% premium.
Price
$73.48
Fair Value
$18.00
Uncertainty
Medium
1-Star Price
$75.20
5-Star Price
$85.00
Economic Moat
Qcvcgml
Capital Allocation
Fmwdnxk

Bulls Say, Bears Say

Bulls

Hologic was first to market with an FDA-approved 3D mammography platform in the U.S., giving it a considerable head start in its installed base against GE and Siemens.

Bears

Shifts in screening guidelines and disruptive technologies can have a significant effect on Hologic's business as we saw with the advent of HPV diagnostics on traditional Pap tests.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HOLX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$73.53
Day Range
$72.7873.55
52-Week Range
$64.0282.45
Bid/Ask
$72.29 / $74.79
Market Cap
$17.15 Bil
Volume/Avg
1.2 Mil / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
19.18
Price/Sales
4.52
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
5.84%

Company Profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
6,990

Competitors

Valuation

Metric
HOLX
QGEN
GE
Price/Earnings (Normalized)
19.1819.7848.66
Price/Book Value
3.542.505.98
Price/Sales
4.524.662.58
Price/Cash Flow
16.1313.8742.64
Price/Earnings
HOLX
QGEN
GE

Financial Strength

Metric
HOLX
QGEN
GE
Quick Ratio
2.961.210.76
Current Ratio
3.971.841.17
Interest Coverage
4.868.005.22
Quick Ratio
HOLX
QGEN
GE

Profitability

Metric
HOLX
QGEN
GE
Return on Assets (Normalized)
10.32%5.68%2.83%
Return on Equity (Normalized)
18.62%9.46%15.41%
Return on Invested Capital (Normalized)
11.95%6.07%9.19%
Return on Assets
HOLX
QGEN
GE
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
SrvvkshtjpDgyk$154.2 Bil
Becton Dickinson & Co
BDX
TtvbfkcVxqqskw$66.1 Bil
Alcon Inc
ALC
PcgrqrwpjSnrmjy$44.2 Bil
ResMed Inc
RMD
KwwhllywHmchlwx$27.8 Bil
Coloplast A/S ADR
CLPBY
DbbttztyySypg$27.0 Bil
West Pharmaceutical Services Inc
WST
TtzfqgftrTfdrd$23.5 Bil
The Cooper Companies Inc
COO
XdcxpjrbnYymst$17.0 Bil
Baxter International Inc
BAX
HrvcgyhnnMgrrk$16.9 Bil
Teleflex Inc
TFX
HmsqbHmfd$10.0 Bil

Sponsor Center